The 9 month study seemed a bit less impressive than what I’d hoped for, but the outcomes still support the claim that common forms of dementia are partly curable.
Out of 25 patients, 21 or 19 improved their cognition compared to the start of the trial, depending on which measure I look at, and 2 or 3 declined.
Even a drug that only prevents Alzheimers from getting worse would be impressive. As far as drug companies making money curing isn’t central. As long as the drug prevents Alzheimers from getting worse that’s a huge win.
Even a drug that only prevents Alzheimers from getting worse would be impressive. As far as drug companies making money curing isn’t central. As long as the drug prevents Alzheimers from getting worse that’s a huge win.